InvestorsHub Logo
Followers 0
Posts 820
Boards Moderated 0
Alias Born 09/04/2019

Re: None

Tuesday, 03/17/2020 3:55:08 PM

Tuesday, March 17, 2020 3:55:08 PM

Post# of 20806
Yes Gov. I have seen your past posts. It appears that Dr. Doki may now have (2) possible strategic business entry paths for CLSI. Yours and Maxis suggestions. One path (Gov's) is a business model pathway that identifies a slow progression which accumulates a group of companies, and/or purchases shares in others for dividends that results in the Birkshire model.

The second business model is what Maxis suggests. This could be a slow or a fast business model which accumulates specific company departments and trained professional(s) to rapidly form a specific company, then rapidly is deployed as market ready to compete in current industry challenges. Hence, the Coronavirus we are witnessing today. Either way, CLSI (IMO) will be moving towards competing as one of these models. The ball in in Dr. Doki's court. (IMO) He might be able to make it happen. Only time will tell.

It also appears that Dr. Doki is an Indian from India. I believe he is Hundu (not sure) and I personally know many Indians who are extremely intelligent with respect to the medical and business industries.

Additionally, the up coming US-INDIA trade deals could possibly aid CLSI due to the fact that CLSI is International (Not sure, just my opinion) and it is a known fact that Hindu Indians are some of the most wealthy individuals. Indian family and community are valuable resources and assets Indians covet through networking. (That may be why you see many family members named in Dr. Doki's businesses).

Anyway, I believe these two directions could be possible. I'm trying to nail this company down to a fork in the road so to speak, and not lose sight of what could really be the correct direction. If anyone else has an opinion, or can add support, please feel free to jump in.